| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
8e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
| mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0002 |
| mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0009 |